Literature DB >> 31471318

SIAH1 ubiquitin ligase mediates ubiquitination and degradation of Akt3 in neural development.

Hyo Rim Ko1,2, Eun-Ju Jin1,2, Sang Bae Lee3, Chung Kwon Kim1,2, Taegwan Yun1,2, Sung-Woo Cho4, Kye Won Park5, Jee-Yin Ahn6,2,7.   

Abstract

Akt signaling is an important regulator of neural development, but the distinctive function of Akt isoforms in brain development presents a challenge. Here we show Siah1 as an ubiquitin ligase that preferentially interacts with Akt3 and facilitates ubiquitination and degradation of Akt3. Akt3 is enriched in the axonal shaft and branches but not growth cone tips, where Siah1 is prominently present. Depletion of Siah1 enhanced Akt3 levels in the soma and axonal tips, eliciting multiple branching. Brain-specific somatic mutation in Akt3-E17K escapes from Siah1-mediated degradation and causes improper neural development with dysmorphic neurons. Remarkably, coexpression of Siah1 with Akt3-WT restricted disorganization of neural development is caused by Akt3 overexpression, whereas forced expression of Siah1 with the Akt3-E17K mutant fails to cope with malformation of neural development. These findings demonstrate that Siah1 limits Akt3 turnover during brain development and that this event is essential for normal organization of the neural network.
© 2019 Ko et al.

Entities:  

Keywords:  Akt PKB; E3 ubiquitin ligase; protein degradation; signal transduction; ubiquitylation (ubiquitination)

Mesh:

Substances:

Year:  2019        PMID: 31471318      PMCID: PMC6802513          DOI: 10.1074/jbc.RA119.009618

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Akt is negatively regulated by the MULAN E3 ligase.

Authors:  Seunghee Bae; Sun-Yong Kim; Jin Hyuk Jung; Yeongmin Yoon; Hwa Jun Cha; Hyunjin Lee; Karam Kim; Jongran Kim; In-Sook An; Jongdoo Kim; Hong-Duck Um; In-Chul Park; Su-Jae Lee; Seon Young Nam; Young-Woo Jin; Jae Ho Lee; Sungkwan An
Journal:  Cell Res       Date:  2012-03-13       Impact factor: 25.617

2.  Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR.

Authors:  Melanie Winter; Dirk Sombroek; Ilka Dauth; Jutta Moehlenbrink; Karin Scheuermann; Johanna Crone; Thomas G Hofmann
Journal:  Nat Cell Biol       Date:  2008-06-08       Impact factor: 28.824

3.  Germline activating AKT3 mutation associated with megalencephaly, polymicrogyria, epilepsy and hypoglycemia.

Authors:  Mark Nellist; Rachel Schot; Marianne Hoogeveen-Westerveld; Rinze F Neuteboom; Elles J T M van der Louw; Maarten H Lequin; Karen Bindels-de Heus; Barbara J Sibbles; René de Coo; Alice Brooks; Grazia M S Mancini
Journal:  Mol Genet Metab       Date:  2014-12-05       Impact factor: 4.797

4.  Hook3 interacts with PCM1 to regulate pericentriolar material assembly and the timing of neurogenesis.

Authors:  Xuecai Ge; Christopher L Frank; Froylan Calderon de Anda; Li-Huei Tsai
Journal:  Neuron       Date:  2010-01-28       Impact factor: 17.173

5.  Siah-1 facilitates ubiquitination and degradation of synphilin-1.

Authors:  Yoshito Nagano; Hiroshi Yamashita; Tetsuya Takahashi; Shosei Kishida; Takeshi Nakamura; Eizo Iseki; Nobutaka Hattori; Yoshikuni Mizuno; Akira Kikuchi; Masayasu Matsumoto
Journal:  J Biol Chem       Date:  2003-09-23       Impact factor: 5.157

6.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.

Authors:  L A Greene; A S Tischler
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

7.  Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B.

Authors:  Sun Sik Bae; Han Cho; James Mu; Morris J Birnbaum
Journal:  J Biol Chem       Date:  2003-09-30       Impact factor: 5.157

8.  Ubiquitin-dependent regulation of phospho-AKT dynamics by the ubiquitin E3 ligase, NEDD4-1, in the insulin-like growth factor-1 response.

Authors:  Chuan-Dong Fan; Michelle A Lum; Chao Xu; Jennifer D Black; Xinjiang Wang
Journal:  J Biol Chem       Date:  2012-11-29       Impact factor: 5.157

9.  Requirement of dendritic Akt degradation by the ubiquitin-proteasome system for neuronal polarity.

Authors:  Dong Yan; Li Guo; Yizheng Wang
Journal:  J Cell Biol       Date:  2006-07-24       Impact factor: 10.539

10.  An AKT3-FOXG1-reelin network underlies defective migration in human focal malformations of cortical development.

Authors:  Seung Tae Baek; Brett Copeland; Eun-Jin Yun; Seok-Kyu Kwon; Alicia Guemez-Gamboa; Ashleigh E Schaffer; Sangwoo Kim; Hoon-Chul Kang; Saera Song; Gary W Mathern; Joseph G Gleeson
Journal:  Nat Med       Date:  2015-11-02       Impact factor: 53.440

View more
  5 in total

Review 1.  Mechanistic advances in axon pathfinding.

Authors:  Laura E McCormick; Stephanie L Gupton
Journal:  Curr Opin Cell Biol       Date:  2020-01-08       Impact factor: 8.382

2.  m6A-induced repression of SIAH1 facilitates alternative splicing of androgen receptor variant 7 by regulating CPSF1.

Authors:  Lei Xia; Qing Han; Xuehui Duan; Yinjie Zhu; Jiahua Pan; Baijun Dong; Weiliang Xia; Wei Xue; Jianjun Sha
Journal:  Mol Ther Nucleic Acids       Date:  2022-03-15       Impact factor: 8.886

3.  Circ-CCNB1 Modulates Trophoblast Proliferation and Invasion in Spontaneous Abortion by Regulating miR-223/SIAH1 axis.

Authors:  Meng-Yu Jing; Lai-di Xie; Xi Chen; Ying Zhou; Meng-Meng Jin; Wei-Hua He; Di-Min Wang; Ai-Xia Liu
Journal:  Endocrinology       Date:  2022-08-01       Impact factor: 5.051

4.  Transcriptome-Wide lncRNA and mRNA Profiling of Spleens from Meishan Pigs at Different Development Stages.

Authors:  Chao Xu; Jing Shi; Rufeng Huang; Zhengchang Wu; Shenglong Wu; Wenbin Bao
Journal:  Animals (Basel)       Date:  2022-10-05       Impact factor: 3.231

5.  SIAH1 reverses chemoresistance in epithelial ovarian cancer via ubiquitination of YBX-1.

Authors:  Wujiang Gao; Lu Chen; Li Lin; Meiling Yang; Taoqiong Li; Hong Wei; Chunli Sha; Jie Xing; Mengxue Zhang; Shijie Zhao; Qi Chen; Wenlin Xu; Yuefeng Li; Xiaolan Zhu
Journal:  Oncogenesis       Date:  2022-03-10       Impact factor: 7.485

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.